Sarah Dunsmore, Ph.D., is a program director in the NIGMS Division of Pharmacology, Physiology, and Biological Chemistry, where she oversees grants in the areas of intracellular mechanisms of signal transduction and sepsis. Dr. Dunsmore serves as the program director for several clinical trials testing novel treatments for sepsis and septic shock.
Prior to joining NIGMS in 2006, Dr. Dunsmore was a faculty member at Harvard Medical School and conducted pulmonary research in a laboratory based at Brigham and Women’s Hospital in Boston, Massachusetts.
Dr. Dunsmore received a B.S. in molecular biology and mathematics from Vanderbilt University in Nashville, Tennessee, and a Ph.D. in physiology from the Pennsylvania State University College of Medicine in Hershey, Pennsylvania.
To contact Dr. Dunsmore, please send email to firstname.lastname@example.org.
If you’re a reporter wishing to interview Dr. Dunsmore, contact the NIGMS Office of Communications and Public Liaison at email@example.com or call 301-496-7301.
This page last reviewed on
5/1/2019 2:46 PM
Connect With Us: